Peregrine Capital Management LLC Acquires 5,759 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Peregrine Capital Management LLC grew its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 1.8% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 320,768 shares of the company’s stock after acquiring an additional 5,759 shares during the period. Peregrine Capital Management LLC’s holdings in Privia Health Group were worth $6,271,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of PRVA. Nordea Investment Management AB raised its position in shares of Privia Health Group by 33.1% during the fourth quarter. Nordea Investment Management AB now owns 349,773 shares of the company’s stock worth $6,953,000 after acquiring an additional 86,910 shares during the last quarter. Victory Capital Management Inc. boosted its stake in shares of Privia Health Group by 402.9% in the 3rd quarter. Victory Capital Management Inc. now owns 179,049 shares of the company’s stock valued at $3,260,000 after purchasing an additional 143,446 shares during the last quarter. Franklin Resources Inc. increased its position in shares of Privia Health Group by 2.2% during the third quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock worth $23,092,000 after buying an additional 28,480 shares during the period. Barclays PLC raised its stake in Privia Health Group by 240.3% during the third quarter. Barclays PLC now owns 224,018 shares of the company’s stock worth $4,079,000 after buying an additional 158,188 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in Privia Health Group by 8.4% in the third quarter. JPMorgan Chase & Co. now owns 188,384 shares of the company’s stock valued at $3,430,000 after buying an additional 14,641 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Stock Performance

NASDAQ:PRVA opened at $25.04 on Wednesday. Privia Health Group, Inc. has a 52-week low of $15.92 and a 52-week high of $25.64. The stock has a fifty day moving average of $21.76 and a 200 day moving average of $20.29. The firm has a market capitalization of $3.00 billion, a price-to-earnings ratio of 250.43, a P/E/G ratio of 3.07 and a beta of 0.87.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the company. Stephens reissued an “overweight” rating and issued a $26.00 price objective on shares of Privia Health Group in a research report on Thursday, January 2nd. JMP Securities reiterated a “market outperform” rating and issued a $26.00 target price on shares of Privia Health Group in a report on Friday, February 14th. Truist Financial increased their price target on Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Needham & Company LLC assumed coverage on shares of Privia Health Group in a research report on Friday, January 10th. They set a “buy” rating and a $25.00 target price on the stock. Finally, Macquarie started coverage on shares of Privia Health Group in a report on Monday, December 16th. They issued an “outperform” rating and a $25.00 price target for the company. Two analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $24.94.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.